Home > Qtrly Results > Dr Reddys Laboratories

Dr Reddys Laboratories
Quarterly Results Analysis [Jun2022]

Dr Reddys Laboratories is part of below Screeners ↓
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for Dr Reddys Laboratories
Please provide your vote to see the results

Dr Reddys Laboratories Quarterly Results

Consolidated Jun2022
UnAudited
Mar2022
Audited
Dec2021
UnAudited
Sep2021
Audited
Jun2021
Audited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
Audited
Revenues ₹5,233 Cr ₹5,475 Cr ₹5,338 Cr ₹5,787 Cr ₹4,945 Cr ₹4,768 Cr ₹4,942 Cr ₹4,911 Cr
Expenses ₹4,292 Cr ₹5,024 Cr ₹4,123 Cr ₹4,427 Cr ₹4,211 Cr ₹3,715 Cr ₹4,403 Cr ₹3,755 Cr
Operating Income ₹941 Cr ₹451 Cr ₹1,216 Cr ₹1,360 Cr ₹735 Cr ₹1,053 Cr ₹539 Cr ₹1,156 Cr
Other Income ₹854 Cr ₹122 Cr ₹56 Cr ₹206 Cr ₹108 Cr ₹83 Cr ₹71 Cr ₹51 Cr
Interest ₹35 Cr ₹32 Cr ₹22 Cr ₹23 Cr ₹19 Cr ₹30 Cr ₹19 Cr ₹25 Cr
Depreciation ₹302 Cr ₹293 Cr ₹294 Cr ₹294 Cr ₹284 Cr ₹309 Cr ₹311 Cr ₹317 Cr
Profit Before Tax ₹1,459 Cr ₹248 Cr ₹956 Cr ₹1,248 Cr ₹539 Cr ₹797 Cr ₹280 Cr ₹866 Cr
Profit After Tax ₹1,180 Cr ₹87 Cr ₹691 Cr ₹971 Cr ₹364 Cr ₹539 Cr ₹13 Cr ₹765 Cr
EPS ₹71.45 ₹5.83 ₹42.63 ₹59.84 ₹22.86 ₹33.49 ₹1.68 ₹46.44
Industry Peers & Returns1W1M1Y
Dr Reddys Laboratories 1.8% -4.9% -9.9%
SUN PHARMACEUTICAL INDUSTRIES 0.1% 4.8% 17.4%
DIVIS LABORATORIES -5% 0.6% -24.6%
CIPLA -1.2% 6.2% 14.2%
GLAND PHARMA 2.7% -3.9% -45.8%
PIRAMAL ENTERPRISES 8.4% 19% -29.1%
CADILA HEALTHCARE 9.6% 7.7% -26.8%
TORRENT PHARMACEUTICALS 1.1% 2.7% 8.1%
ALKEM LABORATORIES -0.6% -8.5% -19.1%

Dr Reddys Laboratories Quarterly Revenues

Revenues
Q-o-Q

-4.42 %

Y-o-Y

5.82 %

Quarters Revenues % Change
Jun2022 ₹5,233 Cr
-4.42
Mar2022 ₹5,475 Cr
2.56
Dec2021 ₹5,338 Cr
-7.75
Sep2021 ₹5,787 Cr
17.02
Jun2021 ₹4,945 Cr
3.71
Mar2021 ₹4,768 Cr
-3.51
Dec2020 ₹4,942 Cr
0.63
Sep2020 ₹4,911 Cr -

Dr Reddys Laboratories Quarterly Operating Profit

Operating Profit
Q-o-Q

108.69 %

Y-o-Y

28.14 %

Quarters Operating Profit % Change
Jun2022 ₹941 Cr
108.69
Mar2022 ₹451 Cr
-62.90
Dec2021 ₹1,216 Cr
-10.60
Sep2021 ₹1,360 Cr
85.13
Jun2021 ₹735 Cr
-30.26
Mar2021 ₹1,053 Cr
95.29
Dec2020 ₹539 Cr
-53.35
Sep2020 ₹1,156 Cr -
Operating Margins
Q-o-Q

118.33 %

Y-o-Y

21.14 %

Quarters Operating Margin% % Change
Jun2022 17.99%
118.33
Mar2022 8.24%
-63.81
Dec2021 22.77%
-3.11
Sep2021 23.5%
58.25
Jun2021 14.85%
-32.78
Mar2021 22.09%
102.47
Dec2020 10.91%
-53.65
Sep2020 23.54% -

Dr Reddys Laboratories Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

1,263.70 %

Y-o-Y

224.24 %

Quarters Profit After Tax % Change
Jun2022 ₹1,180 Cr
1,263.70
Mar2022 ₹87 Cr
-87.48
Dec2021 ₹691 Cr
-28.86
Sep2021 ₹971 Cr
166.93
Jun2021 ₹364 Cr
-32.55
Mar2021 ₹539 Cr
4,114.06
Dec2020 ₹13 Cr
-98.33
Sep2020 ₹765 Cr -
PAT Margins
Q-o-Q

1,326.58 %

Y-o-Y

206.25 %

Quarters PAT Margin(%) % Change
Jun2022 22.54 %
1,326.58
Mar2022 1.58 %
-87.79
Dec2021 12.94 %
-22.88
Sep2021 16.78 %
127.99
Jun2021 7.36 %
-34.92
Mar2021 11.31 %
4,250.00
Dec2020 0.26 %
-98.33
Sep2020 15.57 % -

Dr Reddys Laboratories Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

1,125.56 %

Y-o-Y

212.55 %

Quarters EPS % Change
Jun2022 ₹71.45
1,125.56
Mar2022 ₹5.83
-86.32
Dec2021 ₹42.63
-28.76
Sep2021 ₹59.84
161.77
Jun2021 ₹22.86
-31.74
Mar2021 ₹33.49
1,893.45
Dec2020 ₹1.68
-96.38
Sep2020 ₹46.44 -

You may also like the below Video Courses


SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].